Estabrook Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12
| Closed | -$488 | – | 402 |
|
|
2022
Q4 | $488 | Hold |
12
| – | – | ﹤0.01% | 411 |
|
|
2022
Q3 | $784 | Hold |
12
| – | – | ﹤0.01% | 399 |
|
|
2022
Q2 | $729 | Hold |
12
| – | – | ﹤0.01% | 409 |
|
|
2022
Q1 | $753 | Hold |
12
| – | – | ﹤0.01% | 405 |
|
|
2021
Q4 | $909 | Hold |
12
| – | – | ﹤0.01% | 430 |
|
|
2021
Q3 | $1.34K | Hold |
12
| – | – | ﹤0.01% | 305 |
|
|
2021
Q2 | $1.94K | Hold |
12
| – | – | ﹤0.01% | 300 |
|
|
2021
Q1 | $1.46K | Hold |
12
| – | – | ﹤0.01% | 307 |
|
|
2020
Q4 | $1.84K | Hold |
12
| – | – | ﹤0.01% | 310 |
|
|
2020
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 303 |
|
|
2020
Q2 | $882 | Hold |
12
| – | – | ﹤0.01% | 316 |
|
|
2020
Q1 | $509 | Hold |
12
| – | – | ﹤0.01% | 321 |
|
|
2019
Q4 | $731 | Buy |
+12
| New | +$731 | ﹤0.01% | 327 |
|